Tura Andrea
Research Director
Corso Stati Uniti 4
35127 Padova
Tel 049-8295786
Fax 049-8295763
Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.
Born in 1970, Andrea Tura got the Degree in Electronic Engineering (specialization in Biomedical Engineering) at the University of Bologna, in 1995. He got the PhD in Bioengineering in 1999 with a thesis on mathematical modelling and image analysis on cardiovascular fluid dynamics.
He joined LADSEB-CNR in 1999 and started working on mathematical modelling applied to glucose metabolism. In 2001 he had an experience in a private Company working in the field of tele-home care of subjects with chronic diseases through proper telemedicine instruments and platforms. At the end of the same year he joined again the LADSEB-CNR (then ISIB-CNR) as established investigator. In 2014, he joined IN-CNR.
Currently, he is mainly focused on pancreatic beta-cell function and insulin secretion, insulin sensitivity, insulin clearance, glucose effectiveness and glucagon kinetics. Other interests are flash/continuous glucose monitoring (also through non-invasive techniques) and assessment of glucose homeostasis in hemodialysis. Recently, he has also got interested in some complications of diabetes, especially sarcopenia.
He is author of more than 200 articles in peer-reviewed scientific journals, of which more than 50 with primary role (first or last author). Current H-index (Google Scholar) is 55 (last checked: May 2025).
Main education and work experiences
1995: Degree in Electronic Engineering, Speciality in Biomedicine, at University of Bologna, Italy
1999: PhD in Bioengineering at University of Bologna, Italy
1999-2001: Temporary Investigator at LADSEB-CNR
From 2001 onwards: Established Investigator of CNR (ISIB-CNR, then IN-CNR)
Research interest
- In-silico models and methods for quantitative physiology and quantitative clinical tests, particularly in the field of chronic diseases, such as Type 2 Diabetes and related cardiovascular diseases. Special interest is on models of pancreatic beta-cell function, insulin sensitivity and insulin clearance
- Analysis of sequences of data, with special interest to Continuous Glucose Monitoring data (CGM) for the estimation of glycemic control and glycemic variability
- Glucose monitoring through non-invasive techniques, with special focus on electro-impedance spectroscopy approach
- Monitoring of glucose and sodium concentration during dialysis, through electro-impedance spectroscopy coupled with ion-exchange resins
- Telemedicine for home monitoring of subjects requiring continuous, non-ending health care, based on the use of portable and wearable medical instruments
Selected grants, fellowships and awards
|
2023 - ongoing |
Funding, Project: Sarcopenia in Gestational Diabetes: The SiGnal-D Study (protocol ID: 2022XYXRJN), funded by Ministero dell'Università e della Ricerca, Italy, within the Call PRIN 2022, Role: Principal Investigator (PI) |
|
2022 - 2024 |
Funding, Scholarship: Cloud-based applications for precision medicine in women with gestational diabetes (translated from original title in Italian), funded by Consortium GARR, Italy, within the Call “Orio Carlini”, n. 01/22, GARR protocol ID: U-2022-0003071, 21/10/2022, conferred to Dr. B. Salvatori, for one year of scholarship (then renewed for a second year but ended by Dr. Salvatori at February 2024), Role: Tutor of the scholar (Dr. Salvatori), at the hosting Institution (IN, CNR) |
|
2018 - 2020 |
Funding, Contract: Assessment of endogenous glucose production from model-based analysis of tracer data obtained by mass spectroscopy in renal transplanted patients treated with SGLT-2 inhibitor, funded by U.O. Malattie Metaboliche e Diabetologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy (in the context of project award n. NPRP 8-311-3-062, Qatar National Research Fund), Role: PI/Scientific coordinator |
|
2014 - 2016 |
Funding, Contract: Modelling of in vivo data generated by the Diabetes and Obesity Pharmacology area in Novo Nordisk – Analysis of monkey data, funded by Novo Nordisk A/S, Bagsvaerd, Denmark, Role: PI/Scientific coordinator. Two contract renewals (under similar study titles) , until November 2016 |
|
2012 - 2018 |
Funding, Project: DIabetes REsearCh on paTient stratification (DIRECT), funded by Innovative Medicines Joint Undertaking (IMI JU), reference n. IMI 115317, Role: Participant of the CNR Unit |
|
2011 - 2016 |
Funding, Project: Drug Disease Model Resources (DDMoRe), funded by Innovative Medicines Joint Undertaking (IMI JU), reference n. IMI 115156, Role: Participant of the CNR Unit |
|
2020- ongoing |
Award, Description: Nomination to Adjunct Professorship at the Medical University of Vienna (renewed in 2024, until 2026), https://www.meduniwien.ac.at/web/internationales/adjunct-professorships/adjunct-professorships/#c38446 (last check: May 2025) |
Main collaborations
- Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
- Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
- Malattie Metaboliche e Diabetologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
- Physicians Committee for Responsible Medicine, Washington, USA
- Institute of Endocrinology, Prague, Czech Republic
- Department of Information Engineering, Università Politecnica delle Marche, Ancona, Italy
- Department of Clinical Sciences, Lund University, Lund, Sweden
- German Diabetes Center (DDZ), Düsseldorf, Germany
Link to publications (source: SCOPUS, Google Scholar)
https://www.scopus.com/authid/detail.uri?authorId=7004080711
https://scholar.google.com/citations?hl=en&user=s8dx7fUAAAAJ&view_op=list_works&sortby=pubdate
Link to Web application for clustering in gestational diabetes (CluGDM)